GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.88 $3.18 Friday, 19th Apr 2024 GLYC stock ended at $1.93. This is 10.88% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 15.43% from a day low at $1.88 to a day high of $2.17.
90 days $1.88 $3.53
52 weeks $1.11 $3.53

Historical GlycoMimetics prices

Date Open High Low Close Volume
2020-10-26 $3.22 $3.39 $3.20 $3.32 185 814
2020-10-23 $3.22 $3.33 $3.16 $3.23 439 479
2020-10-22 $3.22 $3.32 $3.10 $3.22 107 220
2020-10-21 $3.33 $3.33 $3.15 $3.19 159 963
2020-10-20 $3.32 $3.38 $3.22 $3.34 152 585
2020-10-19 $3.40 $3.48 $3.28 $3.28 128 106
2020-10-16 $3.26 $3.45 $3.23 $3.35 131 449
2020-10-15 $3.40 $3.41 $3.21 $3.28 253 076
2020-10-14 $3.56 $3.60 $3.43 $3.43 106 814
2020-10-13 $3.52 $3.60 $3.42 $3.56 132 581
2020-10-12 $3.54 $3.60 $3.46 $3.58 118 891
2020-10-09 $3.52 $3.60 $3.48 $3.55 125 026
2020-10-08 $3.51 $3.62 $3.45 $3.53 215 688
2020-10-07 $3.41 $3.53 $3.40 $3.50 247 530
2020-10-06 $3.58 $3.58 $3.32 $3.41 737 107
2020-10-05 $3.17 $3.30 $3.17 $3.27 143 438
2020-10-02 $3.07 $3.22 $3.06 $3.13 115 507
2020-10-01 $3.09 $3.22 $3.06 $3.18 219 916
2020-09-30 $3.17 $3.19 $3.06 $3.07 264 865
2020-09-29 $3.17 $3.27 $3.11 $3.12 192 034
2020-09-28 $3.26 $3.31 $3.18 $3.26 200 545
2020-09-25 $3.22 $3.29 $3.15 $3.23 175 600
2020-09-24 $3.30 $3.30 $3.15 $3.23 284 629
2020-09-23 $3.41 $3.52 $3.31 $3.32 365 253
2020-09-22 $3.47 $3.56 $3.30 $3.41 315 563
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT